Elevance Health Inc. (ELV) EPS CAGR:-2.44%(TTM)
The eps cagr for Elevance Health Inc. (ELV) is -2.44% over the latest trailing 12-month period. EPS CAGR uses precomputed diluted earnings history where available.
The EPS CAGR for Elevance Health Inc. (ELV) stock is -2.44% over the past 12 months. The 3 year CAGR is 0.83% and the 5 year CAGR is 6.67%.The TTM figure compares the trailing 12 months (sum of the latest four quarters) with the 12 months before that. Rows in the history table compare fiscal years, and the quarterly table compares single quarters; the three measure different windows and will differ. EPS (Earnings Per Share) CAGR measures how Elevance Health Inc.'s earnings per share have grown. This is a key metric for valuation and reflects profitability on a per-share basis.
ELV EPS CAGR Chart
Elevance Health Inc. (ELV)
ELV Quarterly EPS Growth (YoY)
EPS growth vs the same quarter one year earlier, last 20 quarters.
ELV EPS CAGR History
| Year | Start EPS | End EPS | Change | % Change | CAGR |
|---|---|---|---|---|---|
| 2025 | $25.81 | $25.18 | $-0.63 | -2.44% | -2.44% |
| 2024 | $25.38 | $25.81 | +$0.43 | +1.69% | +1.69% |
| 2023 | $24.56 | $25.38 | +$0.82 | +3.34% | +3.34% |
| 2022 | $25.25 | $24.56 | $-0.69 | -2.73% | -2.73% |
| 2021 | $18.23 | $25.25 | +$7.02 | +38.51% | +38.51% |
| 2020 | $18.81 | $18.23 | $-0.58 | -3.08% | -3.08% |
| 2019 | $14.53 | $18.81 | +$4.28 | +29.46% | +29.46% |
| 2018 | $14.70 | $14.53 | $-0.17 | -1.16% | -1.16% |
| 2017 | $9.39 | $14.70 | +$5.31 | +56.55% | +56.55% |
| 2016 | $9.73 | $9.39 | $-0.34 | -3.49% | -3.49% |
| 2015 | $9.31 | $9.73 | +$0.42 | +4.51% | +4.51% |
| 2014 | $8.89 | $9.31 | +$0.42 | +4.72% | +4.72% |
| 2013 | $8.26 | $8.89 | +$0.63 | +7.63% | +7.63% |
| 2012 | $7.80 | $8.26 | +$0.46 | +5.90% | +5.90% |
| 2011 | $7.64 | $7.80 | +$0.16 | +2.09% | +2.09% |
| 2010 | $9.96 | $7.64 | $-2.32 | -23.29% | -23.29% |
| 2009 | $4.79 | $9.96 | +$5.17 | +107.93% | +107.93% |
| 2008 | $5.64 | $4.79 | $-0.85 | -15.07% | -15.07% |
| 2007 | $4.93 | $5.64 | +$0.71 | +14.40% | +14.40% |
| 2006 | $4.03 | $4.93 | +$0.90 | +22.33% | +22.33% |
| 2005 | $3.15 | $4.03 | +$0.88 | +27.94% | +27.94% |
| 2004 | $2.80 | $3.15 | +$0.35 | +12.50% | +12.50% |
| 2003 | $2.31 | $2.80 | +$0.49 | +21.21% | +21.21% |
| 2002 | $1.66 | $2.31 | +$0.65 | +39.16% | +39.16% |
| 2001 | $1.10 | $1.66 | +$0.56 | +50.91% | +50.91% |
| 2000 | $0.22 | $1.10 | +$0.88 | +400.00% | +400.00% |
| 1999 | $0.84 | $0.22 | $-0.62 | -73.81% | -73.81% |
Quarterly EPS: QoQ & YoY
| Quarter | Value | QoQ | YoY |
|---|---|---|---|
| Q1 2026 | $8.00 | +223.9% | -17.0% |
| Q4 2025 | $2.47 | -53.6% | +34.2% |
| Q3 2025 | $5.32 | -31.1% | +22.0% |
| Q2 2025 | $7.72 | -19.9% | -22.1% |
| Q1 2025 | $9.64 | +423.9% | -0.1% |
| Q4 2024 | $1.84 | -57.8% | -49.9% |
| Q3 2024 | $4.36 | -56.0% | -20.4% |
| Q2 2024 | $9.91 | +2.7% | +26.6% |
| Q1 2024 | $9.65 | +162.9% | +15.3% |
| Q4 2023 | $3.67 | -33.0% | +0.8% |
| Q3 2023 | $5.48 | -30.0% | -18.1% |
| Q2 2023 | $7.83 | -6.5% | +15.1% |
| Q1 2023 | $8.37 | +129.9% | +13.0% |
| Q4 2022 | $3.64 | -45.6% | -22.6% |
| Q3 2022 | $6.69 | -1.6% | +7.9% |
| Q2 2022 | $6.80 | -8.2% | -7.2% |
QoQ = change vs the prior quarter; YoY = change vs the same quarter a year earlier.
About Elevance Health Inc.
Operating as a major health benefits organization, Elevance Health Inc. commits to guiding consumers, families, and communities across their entire health and wellness path. It facilitates access to vital care, assistance, and tools designed to enable healthier living for approximately 118 million individuals. The company's comprehensive offerings span medical, digital, pharmaceutical, behavioral health, clinical, and other care solutions. Founded in 1944 and based in Indianapolis, Indiana, this entity adopted its current name, Elevance Health Inc., in June 2022, having previously operated as Anthem, Inc.
- Sector
- Healthcare
- Industry
- Medical - Healthcare Plans
- CEO
- Gail Koziara Boudreaux